KRPMA activates to take part in KPMA

Published: 1999-03-03 17:31:00

Updated: 1999-03-03 17:31:00

The KPMA decided to provide more opportunities to the foreign invested company organization, KRPMA to take part in the administration of KPMA for development of domestic pharmaceutical industry in such a globalization era, by increasing significantly number of directors to allocate more seats f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK